Perioperative arginine prevents metastases by accelerating natural killer cell recovery after surgery

Mol Ther. 2022 Oct 5;30(10):3270-3283. doi: 10.1016/j.ymthe.2022.05.024. Epub 2022 May 26.

Abstract

Profound natural killer (NK) cell suppression after cancer surgery is a main driver of metastases and recurrence, for which there is no clinically approved intervention available. Surgical stress is known to cause systemic postoperative changes that negatively modulate NK cell function including the expansion of surgery-induced myeloid-derived suppressor cells (Sx-MDSCs) and a marked reduction in arginine bioavailability. In this study, we determine that Sx-MDSCs regulate systemic arginine levels in the postoperative period and that restoring arginine imbalance after surgery by dietary intake alone was sufficient to significantly reduce surgery-induced metastases in our preclinical murine models. Importantly, the effects of perioperative arginine were dependent upon NK cells. Although perioperative arginine did not prevent immediate NK cell immunoparalysis after surgery, it did accelerate their return to preoperative cytotoxicity, interferon gamma secretion, and activating receptor expression. Finally, in a cohort of patients with colorectal cancer, postoperative arginine levels were shown to correlate with their Sx-MDSC levels. Therefore, this study lends further support for the use of perioperative arginine supplementation by improving NK cell recovery after surgery.

Keywords: arginine; colorectal cancer; immunology; immunotherapy; metastasis; myeloid-derived suppressor cells; natural killer cells; surgery; surgical oncology.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Arginine*
  • Humans
  • Interferon-gamma / metabolism
  • Killer Cells, Natural / metabolism
  • Mice
  • Myeloid-Derived Suppressor Cells*

Substances

  • Interferon-gamma
  • Arginine

Grants and funding